Cargando…

Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid malignancies due to the rapid rate of metastasis and high resistance to currently applied cancer therapies. The complex mechanism underlying the development and progression of PDAC includes interactions between genomic, epig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciernikova, Sona, Earl, Julie, García Bermejo, María Laura, Stevurkova, Viola, Carrato, Alfredo, Smolkova, Bozena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311973/ https://www.ncbi.nlm.nih.gov/pubmed/32521716 http://dx.doi.org/10.3390/ijms21114091

Ejemplares similares

The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
por: Ciernikova, Sona, et al.
Publicado: (2020)

DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines
por: Urbanova, Maria, et al.
Publicado: (2022)

Tumor microbiome – an integral part of the tumor microenvironment
por: Ciernikova, Sona, et al.
Publicado: (2022)

Age and Geographical Distribution in Families with BRCA1/BRCA2 Mutations in the Slovak Republic
por: Ciernikova, Sona, et al.
Publicado: (2006)

Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool
por: Kalinkova, Lenka, et al.
Publicado: (2022)

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
por: Ferguson, L. Paige, et al.
Publicado: (2023)

Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Mikolaskova, Iveta, et al.
Publicado: (2023)

The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
por: Sevcikova, Aneta, et al.
Publicado: (2022)

The Metastatic Process through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy
por: Smolkova, Bozena, et al.
Publicado: (2022)

miR-205-5p Downregulation and ZEB1 Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer
por: Kalinkova, Lenka, et al.
Publicado: (2021)

Probiotic Survey in Cancer Patients Treated in the Outpatient Department in a Comprehensive Cancer Center
por: Ciernikova, Sona, et al.
Publicado: (2016)

Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
por: Wysocka, Olga, et al.
Publicado: (2016)

Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities
por: Myo Min, Kay K., et al.
Publicado: (2023)

Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
por: Bailey, Peter, et al.
Publicado: (2016)

Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma
por: Roy, Shikha, et al.
Publicado: (2021)

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
por: Li, Yan, et al.
Publicado: (2022)

Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
por: Martínez-Bosch, Neus, et al.
Publicado: (2021)

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
por: Parkin, Ashleigh, et al.
Publicado: (2018)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021)

Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
por: Ali, Ahmad, et al.
Publicado: (2022)

The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
por: Loch, Florian N., et al.
Publicado: (2023)

Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
por: Xu, Rui, et al.
Publicado: (2019)

Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma
por: Takagi, Tadataka, et al.
Publicado: (2023)

Analysis of bacteria from intestinal tract of FAP patients for the presence of APC-like sequences
por: Holec, Vladimir, et al.
Publicado: (2012)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
por: Yang, Yefan, et al.
Publicado: (2022)

Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma
por: Mardin, Wolf Arif, et al.
Publicado: (2013)

Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment
por: Elrakaybi, Asmaa, et al.
Publicado: (2022)

Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study
por: Brand, Randall E., et al.
Publicado: (2022)

The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma
por: Xu, Caiming, et al.
Publicado: (2020)

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
por: Malvi, Parmanand, et al.
Publicado: (2022)

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
por: Ashok Kumar, Prashanth, et al.
Publicado: (2023)

AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
por: Sapio, Luigi, et al.
Publicado: (2022)

Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
por: Alonso-Nocelo, Marta, et al.
Publicado: (2023)

Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?
por: Earl, Julie, et al.
Publicado: (2023)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
por: Alors-Pérez, Emilia, et al.
Publicado: (2023)

Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma
por: Roalsø, Marcus T. T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s39ood1q5gtbuf7gs4jm88ogq5